Angiotensin‐converting enzyme 2 and the kidney

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Experimental Physiology

• Publication date

  2008-05-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1113/expphysiol.2007.041350PMID 18223023
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Mas Deficiency in FVB/N Mice Produces Marked Changes in Lipid and Glycemic Metabolism

  2008cited by this paper
• Identification and characterisation of the angiotensin converting enzyme-3 (ACE3) gene: a novel mammalian homologue of ACE

  2007cited by this paper
• The emerging role of ACE2 in physiology and disease†

  2007cited by this paper
• Differential expression of neuronal ACE2 in transgenic mice with overexpression of the brain renin-angiotensin system.

  2007cited by this paper
• Kidney-specific enhancement of ANG II stimulates endogenous intrarenal angiotensinogen in gene-targeted mice.

  2007cited by this paper
• Evidence for Mas-Mediated Bradykinin Potentiation by the Angiotensin-(1-7) Nonpeptide Mimic AVE 0991 in Normotensive Rats

  2007cited by this paper
• Loss of angiotensin-converting enzyme-2 (Ace2) accelerates diabetic kidney injury.

  2007influential reference
• Angiotensin-(1-7) Counterregulates Angiotensin II Signaling in Human Endothelial Cells

  2007cited by this paper
• Characterization of renin-angiotensin system enzyme activities in cultured mouse podocytes.

  2007influential reference
• ACE2 inhibition worsens glomerular injury in association with increased ACE expression in streptozotocin-induced diabetic mice.

  2007cited by this paper
• Blockade of vascular endothelial growth factor signaling ameliorates diabetic albuminuria in mice.

  2006cited by this paper
• ACE and ACE2 Activity in Diabetic Mice

  2006cited by this paper
• Altered blood pressure responses and normal cardiac phenotype in ACE2-null mice.

  2006cited by this paper
• Permselective dysfunction of podocyte-podocyte contact upon angiotensin II unravels the molecular target for renoprotective intervention.

  2006cited by this paper
• Glomerular localization and expression of Angiotensin-converting enzyme 2 and Angiotensin-converting enzyme: implications for albuminuria in diabetes.

  2006cited by this paper
• Loss of Angiotensin-Converting Enzyme-2 Leads to the Late Development of Angiotensin II-Dependent Glomerulosclerosis

  2006influential reference
• Angiotensin-(1-7) inhibits angiotensin II-stimulated phosphorylation of MAP kinases in proximal tubular cells.

  2006influential reference
• ACE2 gene transfer attenuates hypertension-linked pathophysiological changes in the SHR.

  2006cited by this paper
• Distribution of angiotensin-(1-7) and ACE2 in human placentas of normal and pathological pregnancies.

  2006cited by this paper
• Functional expression of the renin-angiotensin system in human podocytes.

  2006cited by this paper
• Tissue gene expression of renin-angiotensin system in human type 2 diabetic nephropathy.

  2006cited by this paper
• Angiotensin-converting enzyme 2 protects from severe acute lung failure

  2005cited by this paper
• Chronic liver injury in rats and humans upregulates the novel enzyme angiotensin converting enzyme 2

  2005cited by this paper
• The role of angiotensin converting enzyme 2 in the generation of angiotensin 1-7 by rat proximal tubules.

  2005cited by this paper
• Angiotensin-converting Enzyme 2 (ACE2), But Not ACE, Is Preferentially Localized to the Apical Surface of Polarized Kidney Cells*

  2005cited by this paper
• Mouse models of diabetic nephropathy.

  2005cited by this paper
• Organ-specific distribution of ACE2 mRNA and correlating peptidase activity in rodents

  2005cited by this paper
• Age- and gender-related difference of ACE2 expression in rat lung

  2005cited by this paper
• Renal ACE2 expression in human kidney disease

  2004influential reference
• Activation of a local tissue angiotensin system in podocytes by mechanical strain.

  2004cited by this paper
• Increased ACE 2 and Decreased ACE Protein in Renal Tubules From Diabetic Mice: A Renoprotective Combination?

  2004cited by this paper
• Angiotensin II type 1 receptor overexpression in podocytes induces glomerulosclerosis in transgenic rats.

  2004cited by this paper
• Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis

  2004cited by this paper
• Ace revisited: A new target for structure-based drug design

  2003cited by this paper
• Enhanced Renal Immunocytochemical Expression of ANG-(1-7) and ACE2 During Pregnancy

  2003cited by this paper
• The intrarenal renin-angiotensin system and diabetic nephropathy.

  2003cited by this paper
• Diabetic kidney disease in the db/db mouse.

  2003cited by this paper
• Characterization of Renal Angiotensin-Converting Enzyme 2 in Diabetic Nephropathy

  2003influential reference
• Modulation of nephrin in the diabetic kidney: association with systemic hypertension and increasing albuminuria

  2002cited by this paper
• The angiotensin-converting enzyme gene family: genomics and pharmacology.

  2002cited by this paper
• Angiotensin-converting enzyme 2 is an essential regulator of heart function

  2002cited by this paper
• Collectrin, a Collecting Duct-specific Transmembrane Glycoprotein, Is a Novel Homolog of ACE2 and Is Developmentally Regulated in Embryonic Kidneys*

  2001cited by this paper
• A Human Homolog of Angiotensin-converting Enzyme

  2000influential reference
• A Novel Angiotensin-Converting Enzyme–Related Carboxypeptidase (ACE2) Converts Angiotensin I to Angiotensin 1-9

  2000influential reference
• Renoprotective benefits of RAS inhibition: from ACEI to angiotensin II antagonists.

  2000cited by this paper
• Angiotensin-(1-7): an update.

  2000cited by this paper
• The importance of the renin-angiotensin system in cardiovascular disease

  1998cited by this paper
• Mice lacking angiotensin-converting enzyme have low blood pressure, renal pathology, and reduced male fertility.

  1996cited by this paper
• Angiotensin-(1-7) dilates canine coronary arteries through kinins and nitric oxide.

  1996cited by this paper
• Angiotensin-converting enzyme inhibition and renal protection. An assessment of implications for therapy.

  1993cited by this paper
• Renal renin-angiotensin system in diabetes: functional, immunohistochemical, and molecular biological correlations.

  1993cited by this paper
• Glomerular epithelial cell changes after ischemia or dehydration. Possible role of angiotensin II.

  1984cited by this paper

• Integrative transcriptomic and metabolomic analyses reveal preliminary molecular mechanisms of gills response to salinity stress in Micropterus salmoides

  2025cites this paper
• Altered distribution and loss of ACE2 into the urine in acute kidney injury.

  2024cites this paper
• Delayed Graft Function and the Renin-angiotensin System

  2024cites this paper
• Pathogenesis: Hemodynamic Alterations

  2022cites this paper
• SARS-CoV-2 Infection, Sex-Related Differences, and a Possible Personalized Treatment Approach with Valproic Acid: A Review

  2022cites this paper
• Investigation of angiotensin-1 converting enzyme 2 gene (G8790A) polymorphism in patients of type 2 diabetes mellitus with diabetic nephropathy in Pakistani population

  2022cites this paper
• Spectrum of Kidney Injury Following COVID-19 Disease: Renal Biopsy Findings in a Single Italian Pathology Service

  2022cites this paper
• A diabetic milieu increases cellular susceptibility to SARS-CoV-2 infections in engineered human kidney organoids and diabetic patients

  2021cites this paper
• Association of renin–angiotensin system blockers with COVID-19 diagnosis and prognosis in patients with hypertension: a population-based study

  2021cites this paper
• Angiotensin Converting Enzyme-2 (ACE-2) role in disease and future in research

  2021cites this paper
• Renin-Angiotensin System Blockers and the Risk of COVID-19–Related Mortality in Patients with Kidney Failure

  2021cites this paper
• Worse progression of COVID‐19 in men: Is testosterone a key factor?

  2020cites this paper
• ACE2/ADAM17/TMPRSS2 Interplay May Be the Main Risk Factor for COVID-19

  2020influential citation
• Hypothesized mechanisms explaining poor prognosis in type 2 diabetes patients with COVID-19: a review

  2020cites this paper
• Commentary on: “Does COVID19 Infect the Brain? If So, Smokers Might Be at a Higher Risk”

  2020cites this paper
• Aqueous humor renin, angiotensin I, and angiotensin II activity in primary open-angle glaucoma

  2020cites this paper
• Single‐cell RNA sequencing analysis of human kidney reveals the presence of ACE2 receptor: A potential pathway of COVID‐19 infection

  2020cites this paper
• Angiotensin-converting enzyme 2 influences pancreatic and renal function in diabetic mice

  2020cites this paper
• Refining the Mouse Subtotal Nephrectomy in Male 129S2/SV Mice for Consistent Modeling of Progressive Kidney Disease With Renal Inflammation and Cardiac Dysfunction

  2019cites this paper
• Spironolactone rescues renal dysfunction in obstructive jaundice rats by upregulating ACE2 expression

  2018cites this paper
• Characterization of ACE and ACE2 Expression within Different Organs of the NOD Mouse

  2017cites this paper
• Néphropathie diabétique

  2017cites this paper
• Perindoprilat changes ANG (1-9) production in renal arteries isolated from young spontaneously hypertensive rats after ANG I incubation.

  2016cites this paper
• Angiotensin-converting enzyme 2 ameliorates renal fibrosis by blocking the activation of mTOR/ERK signaling in apolipoprotein E-deficient mice.

  2016cites this paper
• Diabetic kidney disease: from physiology to therapeutics

  2014cites this paper
• Effect of Insulin on ACE2 Activity and Kidney Function in the Non-Obese Diabetic Mouse

  2014cites this paper
• Multiple functions of angiotensin-converting enzyme 2 and its relevance in cardiovascular diseases.

  2013cites this paper
• Enzymatic processing of angiotensin peptides by human glomerular endothelial cells.

  2012cites this paper
• Vasoactive Molecules and the Kidney

  2012cites this paper
• Experimental Investigation of Acute and Delayed Renal Effect of Exogenous Thyroxine

  2012cites this paper
• High-salt diet increases glomerular ACE/ACE2 ratio leading to oxidative stress and kidney damage.

  2012cites this paper
• Circulating Angiotensin-Converting Enzyme 2 Activity in Kidney Transplantation: A Longitudinal Pilot Study

  2012cites this paper
• Benefits of catalase overexpression in renal proximal tubular cells.

  2010cites this paper
• Trilogy of ACE2: A peptidase in the renin–angiotensin system, a SARS receptor, and a partner for amino acid transporters

  2010cites this paper
• Advances in the renin angiotensin system focus on angiotensin-converting enzyme 2 and angiotensin-(1-7).

  2010cites this paper
• Therapeutic strategies in the treatment of diabetic nephropathy - a translational medicine approach.

  2009cites this paper
• Angiotensin-converting enzyme 2: implications for blood pressure and kidney disease

  2009cites this paper
• Impairment of the angiotensin-converting enzyme 2–angiotensin-(1-7)-Mas axis contributes to the acceleration of two-kidney, one-clip Goldblatt hypertension

  2009cites this paper
• Recent advances in the renin–angiotensin system: angiotensin‐converting enzyme 2 and (pro)renin receptor

  2008cites this paper
• Pharmacologic modulation of ACE2 expression

  2008cites this paper